Princess Margaret Cancer Consortium leadership and members share updates with the Network

On Thursday, March 20, 2025, leadership and researchers from the Princess Margaret Cancer Consortium (PM2C) presented their work to Network members as part of the MOHCCN seminar series.
This series, which is being held periodically throughout the year, features virtual talks from MOHCCN leadership, investigators and trainees from each region, providing a platform for MOHCCN members to share their ongoing work in precision oncology with the wider Network.
This event was co-chaired by James Pereira, a member of the MOHCCN Patient Working Group, and by Véronique LeBlanc, PhD, Program Manager and Scientific Writer, MOHCCN.
Watch the full video
Speakers
Consortium Activities Update
- Lillian Siu, MD, FRCPC - Medical oncologist, Princess Margaret Cancer Centre, University Health Network; MOHCCN consortium lead
Research Presentations
- Bringing whole genome transcriptome sequencing (WGTS) to patient care and clinicians: the prospective MOHCCN-O study and Molecular Tumor Board at PM2C.
- Enrique Sanz-Garcia, MD, PhD - Medical oncologist and clinician-investigator, Princess Margaret Cancer Centre, University Health Network; MOHCCN consortium lead
- View scientific and plain language abstracts
- Evaluating shallow Whole Genome Sequencing (sWGS) Prior to deep-WGS Assays to Estimate Tumor Purity in Oncology
- Carlos Diego Holanda Lopes, MD - Clinical research fellow, supervised by Jeffrey Bruce, PhD and Philippe Bedard, MD, Princess Margaret Cancer Centre, University Health Network
- View scientific and plain language abstracts
Related Team Member
-
Sherri
Consortium LeaderMOHCCN Steering CommitteeWorking Group Member
Christian
-
Regional Consortia
Atlantic Cancer Consortium
- Prince Edward Island
- New Brunswick
- Newfoundland and Labrador
- Nova Scotia
We have rallied our region’s leading cancer researchers, institutions and care facilities to unite around this vision to enhance inter-institutional and inter-provincial cancer research collaboration,...Read more -
Regional Consortia
Atlantic Cancer Consortium
- Prince Edward Island
- New Brunswick
- Newfoundland and Labrador
- Nova Scotia
We have rallied our region’s leading cancer researchers, institutions and care facilities to unite around this vision to enhance inter-institutional and inter-provincial cancer research collaboration,...Read more -
Regional Consortia
Atlantic Cancer Consortium
- Prince Edward Island
- New Brunswick
- Newfoundland and Labrador
- Nova Scotia
We have rallied our region’s leading cancer researchers, institutions and care facilities to unite around this vision to enhance inter-institutional and inter-provincial cancer research collaboration,...Read more -
Regional Consortia
Atlantic Cancer Consortium
- Prince Edward Island
- New Brunswick
- Newfoundland and Labrador
- Nova Scotia
We have rallied our region’s leading cancer researchers, institutions and care facilities to unite around this vision to enhance inter-institutional and inter-provincial cancer research collaboration,...Read more -
Regional Consortia
Atlantic Cancer Consortium
- Prince Edward Island
- New Brunswick
- Newfoundland and Labrador
- Nova Scotia
We have rallied our region’s leading cancer researchers, institutions and care facilities to unite around this vision to enhance inter-institutional and inter-provincial cancer research collaboration,...Read more
Related News
-
Novel approach helps MOHCCN Clinician-Scientist uncover rare cancer cells responsible for driving tumour growth in breast cancer models
In a new study published in Cell Reports, a research team led by MOHCCN Clinician-Scientist Award holder, Dr. Long V. Nguyen (University Health Network - Princess Margaret Cancer Centre), has revealed... -
BC Cancer Consortium leadership and members share updates with the Network
The presentation was part of MOHCCN Seminar Series, which features virtual talks from MOHCCN research partner investigators and trainees, providing a platform for MOHCCN members to share their ongoing... -
Study finds key molecule that fuels the transformation of some prostate and lung cancers into more aggressive forms
A new study by a team of Toronto-based researchers partly funded by the Marathon of Hope Cancer Centres Network has revealed that a specific type of circular RNA (circRNA) plays a crucial role in tran... -
New study shows how comprehensive sequencing and molecular tumour boards can help put precision oncology into practice
Precision oncology is a promising approach for personalized cancer treatments. A new study from a Network-funded team demonstrates how it can be put into practice, and the challenges that remain to ma...